173 related articles for article (PubMed ID: 11809607)
1. Successful treatment of ocular leishmaniasis.
Abrishami M; Soheilian M; Farahi A; Dowlati Y
Eur J Dermatol; 2002; 12(1):88-9. PubMed ID: 11809607
[TBL] [Abstract][Full Text] [Related]
2. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate.
Martinez S; Gonzalez M; Vernaza ME
Clin Infect Dis; 1997 Feb; 24(2):165-9. PubMed ID: 9114142
[TBL] [Abstract][Full Text] [Related]
5. A chronic mutilating rhinopathy with a delayed diagnosis of mucocutaneous leishmaniasis.
Karimbil SK; Kumari S; Celine MI; Joy A
Int J Dermatol; 2010 Apr; 49(4):426-9. PubMed ID: 20465699
[TBL] [Abstract][Full Text] [Related]
6. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis.
Llanos-Cuentas A; EchevarrÃa J; Cruz M; La Rosa A; Campos P; Campos M; Franke E; Berman J; Modabber F; Marr J
Clin Infect Dis; 1997 Sep; 25(3):677-84. PubMed ID: 9314461
[TBL] [Abstract][Full Text] [Related]
8. Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
Llanos-Cuentas A; Tulliano G; Araujo-Castillo R; Miranda-Verastegui C; Santamaria-Castrellon G; Ramirez L; Lazo M; De Doncker S; Boelaert M; Robays J; Dujardin JC; Arevalo J; Chappuis F
Clin Infect Dis; 2008 Jan; 46(2):223-31. PubMed ID: 18171254
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
[TBL] [Abstract][Full Text] [Related]
11. Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment.
Marovich MA; Lira R; Shepard M; Fuchs GH; Kruetzer R; Nutman TB; Neva FA
Clin Infect Dis; 2001 Oct; 33(7):1076-9. PubMed ID: 11528583
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
Momeni AZ; Aminjavaheri M
Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
[TBL] [Abstract][Full Text] [Related]
13. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
[TBL] [Abstract][Full Text] [Related]
15. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of antimony-resistant cutaneous leishmaniasis].
Kremsner P; Lang I; Kollaritsch H
Hautarzt; 1987 Dec; 38(12):733-5. PubMed ID: 2830206
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous leishmaniasis: a report of two cases seen at a tertiary dermatological centre in Singapore.
Tan HH; Wong SS; Ong BH
Singapore Med J; 2000 Apr; 41(4):179-81. PubMed ID: 11063184
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cutaneous leishmaniasis in travelers 2009.
Blum JA; Hatz CF
J Travel Med; 2009; 16(2):123-31. PubMed ID: 19335813
[No Abstract] [Full Text] [Related]
20. [Cutaneous leishmaniasis in 49 patients in The Netherlands].
Faber WR; Becht M; van Ginkel CJ; van der Kaay HJ; Vermeer BJ; Kager PA
Ned Tijdschr Geneeskd; 1991 Feb; 135(6):229-33. PubMed ID: 1848686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
